Home » News » Hard blow for Ipsen who withdraws its application for approval of palovarotene in the United States

Hard blow for Ipsen who withdraws its application for approval of palovarotene in the United States

Your email is handled by our press title which, depending on the title, belongs to one of the following companies of: Groupe Moniteur Nanterre B 403 080 823, IPD Nanterre 490 727 633, Groupe Industrie Service Info (GISI) Nanterre 442 233 417. This company or any company of the Infopro Digital Group may use it in order to offer you, on their behalf or that of their customers, products and / or services useful for your professional activities. To exercise your rights, oppose them or for more information: Personal data charter.

To close

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.